Exact Mass: 522.1408428
Exact Mass Matches: 522.1408428
Found 410 metabolites which its exact mass value is equals to given mass value 522.1408428
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Iridin
Iridin is a glycosyloxyisoflavone that is irigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It has a role as a plant metabolite. It is a hydroxyisoflavone, a monosaccharide derivative, a member of 4-methoxyisoflavones and a 7-hydroxyisoflavones 7-O-beta-D-glucoside. It is functionally related to an irigenin. Iridin is a natural product found in Iris milesii, Iris tectorum, and other organisms with data available. See also: Iris versicolor root (part of). A glycosyloxyisoflavone that is irigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. Iridin is an isoflavone isolated from Iris milesii[1]. Iridin is an isoflavone isolated from Iris milesii[1].
Cefoselis
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Fenoprofen Calcium
C30H26CaO6 (522.1355206000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Salviaflaside
Salviaflaside is found in herbs and spices. Salviaflaside is isolated from Salvia (sage) species. Isolated from Salvia (sage) subspecies Salviaflaside is found in herbs and spices.
Spinatoside
Spinatoside is found in green vegetables. Spinatoside is isolated from spinach (Spinacia oleracea) leaves. Isolated from spinach (Spinacia oleracea) leaves. Spinatoside is found in green vegetables and spinach.
Sudachiin A
Sudachiin A is found in citrus. Sudachiin A is isolated from Citrus sudachi peel. Isolated from Citrus sudachi peel. Sudachiin A is found in citrus.
3,4',5,6-Tetrahydroxy-3',7-dimethoxyflavone 3-glucuronide
3,4,5,6-Tetrahydroxy-3,7-dimethoxyflavone 3-glucuronide is found in green vegetables. 3,4,5,6-Tetrahydroxy-3,7-dimethoxyflavone 3-glucuronide is isolated from spinach.
3,3',5,6-Tetrahydroxy-4',7-dimethoxyflavone 3-glucuronide
3,3,5,6-Tetrahydroxy-4,7-dimethoxyflavone 3-glucuronide is found in green vegetables. 3,3,5,6-Tetrahydroxy-4,7-dimethoxyflavone 3-glucuronide is a constituent of spinach.
Myricetin 3-(6-acetylgalactoside)
Constituent of the flowers of Trifolium repens (white clover). Myricetin 3-(6-acetylgalactoside) is found in many foods, some of which are herbs and spices, pulses, tea, and green vegetables. Myricetin 3-(6-acetylgalactoside) is found in green vegetables. Myricetin 3-(6-acetylgalactoside) is a constituent of the flowers of Trifolium repens (white clover)
Ticagrelor
Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
2-{4-[(2s)-4-[(6-Aminopyridin-3-Yl)sulfonyl]-2-(Prop-1-Yn-1-Yl)piperazin-1-Yl]phenyl}-1,1,1,3,3,3-Hexafluoropropan-2-Ol
Dichloromethotrexate
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents
Prednisolone phthalate
Cefoselis
5,2-Dihydroxy-7,8,6-trimethoxyflavanone 2-O-glucuronide
Centaurein
Neocandenatone
5,7,4-Trihydroxy-6,8,3-trimethoxyflavone 7-glucoside
5,7,4-Trihydroxy-6,3,5-trimethoxyisoflavone 7-O-glucoside
5,2,6-Trihydroxy-6,7,8-trimethoxyflavone 2-glucoside
Tridaxidone
Quercetagetin 6,3,4-trimethyl ether 3-glucoside
Hibiscetin 8,3,5-trimethyl ether 3-rhamnoside
5,4-Dihydroxy-6,7,8,3-tetramethoxyflavone 4-galactoside
5,7,4-Trihydroxy-6,8,3-trimethoxyflavone 4-glucoside
1,1,8,8-Tetrahydroxy-3-(hydroxymethyl)-3-methyl[2,2-bianthracene]-9,9,10,10-tetrone
6-methoxy-7-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-coumarin|6-Methoxy-7-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-cumarin|acetylated scopolin|scopolin tetraacetate
5-Hydroxy-7-methoxy-3,4-diacetoxy-6-(6,6-dimethyl-2-oxo-cyclohexylmethyl)flavone
10-O-benzoyl-10-O-deacetyl-11-demethoxy-11-ethoxydaphylloside|ethyl(1S,4aS,5S,7aS)-7-[(benzoyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a,-tetrahydro-5-hydroxycyclopenta[c]pyran-4-carboxylate
(2S, 3R)-9-(2-acetoxymethyl-5,6-dimethoxy-2,3-dihydrobenzofuran-3-yloxy)-3,10-dimethoxy-6H-dibenzopyran-6-one|(2S, 3R)-9-(2-acetoxymethyl-5,6-dimethoxy-2,3-dihydrobenzo[b]furan-3-yloxy)-3,10-dimethoxy-6H-dibenzo[b,d]pyran-6-one|(2S,3R)-3,10-dimethoxy-9-O-(5,6-dimethoxy-2-acetoxymethyldihydrobenzofuran-3-yl)-dibenz--pyran-6-one
4-cumaryl alcohol 4-O-beta-D-glucopyranoside peracetate|[4-(3-Acetoxy-trans-propenyl)-phenyl]-(tetra-O-acetyl-beta-D-glucopyranosid)|[4-(3-acetoxy-trans-propenyl)-phenyl]-(tetra-O-acetyl-beta-D-glucopyranoside)
3,4,3-trimethoxyflavellagic acid 4-O-beta-D-glucopyranoside
benzyl 2-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosylbenzoate
1beta-(3-furanoyloxy)-9alpha-benzoyloxy-8beta-acetoxy-2-oxo-3-enedihydro-beta-agarofuran
isorhamnetin 3-O-(3-O-acetyl)-beta-D-glucopyranoside|mumeflavonoside A
5,6,7,3,4,5-hexahydroxyflavone-7-O-(6-O-acetyl)-beta-D-glucopyranoside
beta-D-fructofuranosyl-alpha-D-(6-syringyl)-glucopyranoside
4alpha,5,8-trihydroxy-alpha-tetralone 5-O-beta-D-[6-O-(3,5-dihydroxy-4-methoxybenzoyl)]glucopyranoside
QHJ45RLC3Q
Protopseudohypericin is a natural product found in Hypericum perforatum with data available.
Salviaflaside
Salviaflaside is a glycoside. Salviaflaside is a natural product found in Salvia deserti, Salvia deserta, and other organisms with data available.
10-O-Trans-p-methoxycinnamoylcatalpol
Ticagrelor
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6-dimethoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
5-hydroxy-3-(5-hydroxy-2,4-dimethoxyphenyl)-6-methoxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
C25H30O12_(5E)-5-[2-(beta-D-Glucopyranosyloxy)ethylidene]-4-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]oxy}-2-methyl-1-cyclopentene-1-carboxylic acid
C25H30O12_(1S,4aS,6S,7R,7aS)-1-(beta-D-Glucopyranosyloxy)-6-{[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]oxy}-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid
C25H30O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,6,7,7a-hexahydro-7-hydroxy-1-[[2-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-7-methyl-, (1S,4aS,7R,7aS)
5-hydroxy-3-(5-hydroxy-2,4-dimethoxyphenyl)-6-methoxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Cys His Thr Tyr
Cys His Tyr Thr
Cys Asn Thr Trp
Cys Asn Trp Thr
Cys Gln Ser Trp
Cys Gln Trp Ser
Cys Ser Gln Trp
Cys Ser Trp Gln
Cys Thr His Tyr
Cys Thr Asn Trp
Cys Thr Trp Asn
Cys Thr Tyr His
Cys Trp Asn Thr
Cys Trp Gln Ser
Cys Trp Ser Gln
Cys Trp Thr Asn
Cys Tyr His Thr
Cys Tyr Thr His
Asp Asp His His
Asp Glu Glu Met
Asp Glu Met Glu
Asp His Asp His
Asp His His Asp
Asp Met Glu Glu
Glu Asp Glu Met
Glu Asp Met Glu
Glu Glu Asp Met
Glu Glu Met Asp
Glu Met Asp Glu
Glu Met Glu Asp
His Cys Thr Tyr
His Cys Tyr Thr
His Asp Asp His
His Asp His Asp
His His Asp Asp
His Thr Cys Tyr
His Thr Tyr Cys
His Tyr Cys Thr
His Tyr Thr Cys
Met Asp Glu Glu
Met Glu Asp Glu
Met Glu Glu Asp
Asn Cys Thr Trp
Asn Cys Trp Thr
Asn Thr Cys Trp
Asn Thr Trp Cys
Asn Trp Cys Thr
Asn Trp Thr Cys
Gln Cys Ser Trp
Gln Cys Trp Ser
Gln Ser Cys Trp
Gln Ser Trp Cys
Gln Trp Cys Ser
Gln Trp Ser Cys
Ser Cys Gln Trp
Ser Cys Trp Gln
Ser Gln Cys Trp
Ser Gln Trp Cys
Ser Trp Cys Gln
Ser Trp Gln Cys
Thr Cys His Tyr
Thr Cys Asn Trp
Thr Cys Trp Asn
Thr Cys Tyr His
Thr His Cys Tyr
Thr His Tyr Cys
Thr Asn Cys Trp
Thr Asn Trp Cys
Thr Trp Cys Asn
Thr Trp Asn Cys
Thr Tyr Cys His
Thr Tyr His Cys
Trp Cys Asn Thr
Trp Cys Gln Ser
Trp Cys Ser Gln
Trp Cys Thr Asn
Trp Asn Cys Thr
Trp Asn Thr Cys
Trp Gln Cys Ser
Trp Gln Ser Cys
Trp Ser Cys Gln
Trp Ser Gln Cys
Trp Thr Cys Asn
Trp Thr Asn Cys
Tyr Cys His Thr
Tyr Cys Thr His
Tyr His Cys Thr
Tyr His Thr Cys
Tyr Thr Cys His
Tyr Thr His Cys
Myricetin 3-(6-acetylgalactoside)
Sudachiin A
3,4',5,6-Tetrahydroxy-3',7-dimethoxyflavone 3-glucuronide
3,3',5,6-Tetrahydroxy-4',7-dimethoxyflavone 3-glucuronide
5-Hydroxy-3-(5-hydroxy-2,4-dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl hexopyranoside
(r)-1-{(s)-2-[di(2-furyl)phosphino]ferrocenyl}ethyldi-tert.-butylphosphine
4-(Methanesulfonyloxymethyl)-1,2-O-diacetoxy-3,5-O-dibenzyl-alpha-D-erythro-pentofuranose
triphenyl-(3,4,5-trimethoxy-benzyl)-phosphonium, bromide
Lenvatinib Mesylate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
(S)-1-{(R)-2-[DI(2-FURYL)PHOSPHINO]FERROCENYL}ETHYLDI-TERT.-BUTYLPHOSPHINE
C23H31O2P2.C5H5.Fe (522.1539806)
Piperazine, 1,4-bis[(4-chlorophenyl)phenylmethyl]-, dihydrochloride
2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-[(4-nitrophenyl)methyl] ester
MRS1334 is a potent and selective human adenosine A3 receptor antagonist with Kis of 2.69 nM, >100 nM, >100 nM for hA3, rA1, rA2A, respectively. MRS1334 blocks the protective effect of Cl-IB-MECA leading to significant bradycardia and elevated ST segment[1][2]. MRS1334 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
(2R)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3-[4-hydroxy-3-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]propanoic acid
3-[[3-amino-2-(2-hydroxyethyl)pyrazol-1-ium-1-yl]methyl]-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
23,26-Dihydroxy-23-(2-hydroxyacetyl)-1,24-dimethyl-3,12-dioxahexacyclo[14.11.0.02,13.05,10.019,27.020,24]heptacosa-2(13),5,7,9,15-pentaene-4,11,14-trione
3,15-Di-O-acetylbruceolide
A quassinoid that is the 3,15-di-O-acetyl derivative of bruceolide. It has been isolated from Brucea javanica and Brucea sumatrana.
4-methyl-N-[5-[2-[2-[[1-[(4-methylphenyl)methyl]indol-3-yl]methylidene]hydrazinyl]-2-oxidanylidene-ethyl]-1,3,4-thiadiazol-2-yl]benzamide
4-[2-[2-[(Z)-[1-[(4-fluorophenyl)methyl]-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl]-1H-indol-3-yl]ethylamino]-4-oxobutanoic acid
5-(beta-D-glucopyranosyloxy)-1H-naphtho[2,3-c]pyran-10-yl beta-D-quinovopyranoside
[(1R)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
[(1S)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(2-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
N-(3-chloro-2-methylphenyl)-3-(3,4-dimethoxyphenyl)-3-oxo-2-(3-propylbenzimidazol-3-ium-1-yl)propanethioamide
(1R,2S,3R,5S)-3-[7-[[(1R,2R)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
5-hydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-7-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
(6R,7S)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[2-(2-hydroxyethyl)-3-iminopyrazol-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3,4,5,6-Tetrahydroxy-3,7-dimethoxyflavone 3-glucuronide
clarinoside
A naphthopyran that is 1H-naphtho[2,3-c]pyran-5,10-diol in which the hydroxy group at position 5 (furthest from the pyran oxygen) has been converted to the corresponding beta-D-glucoside, while that at position 10 has been converted to the corresponding 6-deoxy-beta-D-glucopyranoside (beta-D-quinovoside). It was isolated from the flowered aerial parts of the annual plant Mitracarpus scaber.
3-Methyl-GABA
3-Methyl-GABA is a potent GABA aminotransferase activator. 3-Methyl-GABA can fit the binding pocket of GABAA receptor (GABAaR). 3-Methyl-GABA can activate L-glutamic acid decarboxylase (GAD). 3-Methyl-GABA has anticonvulsant activity[1][2].
5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
3-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxyxanthen-9-one
5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
3-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxyxanthen-9-one
[(2r,3r,4s,5r,6s)-3,4,5-tris(acetyloxy)-6-[(6-methoxy-2-oxochromen-7-yl)oxy]oxan-2-yl]methyl acetate
7-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxyxanthen-9-one
(5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,7-dimethoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
(2e)-3-(4-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}phenyl)prop-2-en-1-yl acetate
[(2r,3r,4s,5r,6s)-6-{[5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
(2s,3r,4s,5s,6r)-2-{[(4as,5r)-5-hydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5h-cyclopenta[c]pyran-4a-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,10s)-6-[(5-hydroxy-6-methoxy-3-phenyl-1-benzofuran-2-yl)methyl]-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
6-[4-(5,7-dihydroxy-3,6-dimethoxy-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
4-[(2z,7r)-7-(2-hydroxy-4-methoxyphenyl)-4-(4-hydroxyphenyl)-6h,7h,8h-pyrano[3,2-g]chromen-2-ylidene]-3-methoxycyclohexa-2,5-dien-1-one
(2s,3r,4s,5r,6r)-2-{3-hydroxy-5-[(1e)-2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-({[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(4r,11s,14s,17r)-14-[(1r)-1-hydroxyethyl]-4,17-dimethyl-11-(2-methylpropyl)-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol
2-(4-hydroxy-2-methoxyphenyl)-4-(4-hydroxyphenyl)-6-(7-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl)chromen-7-one
2-{3-hydroxy-5-[2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
9-methoxy-3-[({8-methoxy-6-methyl-10,14-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,4,6,8,11-hexaen-15-yl}oxy)methyl]-8-methylnaphtho[2,3-b]furan-4-carbaldehyde
5-hydroxy-7-methoxy-3',4'-diacetoxy-6-(6,6-dimethyl-2-oxo-cyclohexylmethyl)flavone
{"Ingredient_id": "HBIN011655","Ingredient_name": "5-hydroxy-7-methoxy-3',4'-diacetoxy-6-(6,6-dimethyl-2-oxo-cyclohexylmethyl)flavone","Alias": "NA","Ingredient_formula": "C29H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10396","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
benzenepropanoicacid,8-{[7'-(3',4'-dihydroxy-phenyl)-9'-oxo-7'-propenyl]oxy}-3-(1''-o-β-d-glucopyranosyl)-4-hydroxy-[r-(e)]
{"Ingredient_id": "HBIN017772","Ingredient_name": "benzenepropanoicacid,8-{[7'-(3',4'-dihydroxy-phenyl)-9'-oxo-7'-propenyl]oxy}-3-(1''-o-\u03b2-d-glucopyranosyl)-4-hydroxy-[r-(e)]","Alias": "NA","Ingredient_formula": "C24H26O13","Ingredient_Smile": "C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2223","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}